- Embattled MiMedx (OTC:MDXG +0.1%) is treading water on below-average volume on the heels of a Wall Street Journal article rehashing the company's alleged misbehavior in booking sales of its skin grafts.
- Previously: CEO Petit out at MiMedx (July 2)
- Previously: MiMedx to restate six years of financial statements, withdraws 2018 guidance (June 7)
MiMedx holds steady after WSJ article
Recommended For You
About MDXG Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MDXG | - | - |
| MiMedx Group, Inc. | ||